Browsing Tag
stem cell therapy
7 posts
Longeveron Inc. appoints Stephen H. Willard as CEO ahead of pivotal Phase 2b stem cell data
Find out why Longeveron Inc.’s CEO appointment comes at a critical clinical and financial moment and what it could mean for investors and regenerative medicine.
BrainStorm Cell Therapeutics (OTCQB: BCLI) narrows Q3 2025 loss as ALS trial preps advance and cash runway tightens
BrainStorm Cell Therapeutics narrows Q3 loss and prepares for pivotal ALS trial. Find out why 2026 could be a make-or-break year for the biotech company.
Pollon Life files for Hong Kong IPO: Is Jack Ma’s stem cell bet about to pay off?
Find out how Pollon Life, backed by Jack Ma’s Yunfeng Capital, is planning a Hong Kong IPO and what it signals for China’s biotech revival.
Stem cell-based diabetes therapies at ADA 2025 show promise in eliminating insulin use for type 1 patients
VX-880 and immune-shielded stem cell islets show strong promise in clinical trials at ADA 2025, offering new possibilities in type 1 diabetes treatment.
Unbelievable cure: German man beats HIV after revolutionary treatment
In a groundbreaking development in the fight against HIV, a 60-year-old German man has been declared free of…
ENCell announces promising results from Phase 1 CMT1A trial of EN001
ENCell Co., Ltd., a South Korean biotech leader specializing in Cell and Gene Therapy (CGT), has unveiled promising…
Citius seeks FDA nod for evaluating stem cell therapy for ARDS in COVID-19
Citius Pharmaceuticals has made a Pre-IND submission to the US Food and Drug Administration for a novel stem…